| Typicality: | 0.376 |
| Saliency: | 0.295 |
| at ibex preclinical research inc. | 2 | location |
| protocol → be approved by → the iacuc | 10 |
| protocol → be approved by → iacuc | 5 |
| negative | neutral | positive |
| 0.101 | 0.613 | 0.286 |
| Raw frequency | 15 |
| Normalized frequency | 0.295 |
| Modifier score | 0.500 |
| Perplexity | 48.659 |